{"id":"W2977259025","doi":"10.1200/jco.2012.30.15_suppl.551","title":"Safety of everolimus for women over 65 years of age with advanced breast cancer (BC): 12.5-mo follow-up of BOLERO-2.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Everolimus; Exemestane; Internal medicine; Adverse effect; Tolerability; Rash; Breast cancer; Population; Aromatase inhibitor; Placebo; Oncology; Cancer; Aromatase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003053695,0.000595828,0.001488313,0.0005730177,0.0004882777,0.0008080828,0.0004908761,0.001247431,0.002653413],"category_scores_gemma":[0.002070539,0.0003251015,0.002168201,0.0005160059,0.0003296765,0.0009156041,0.0005248484,0.001419209,0.0007799884],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005829436,"about_ca_system_score_gemma":0.0005492936,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001155719,"about_ca_topic_score_gemma":0.002062392,"domain_scores_codex":[0.9994313,0.0001929429,0.00005383218,0.0001123132,0.0001068193,0.0001026631],"domain_scores_gemma":[0.9983229,0.000233919,0.000760069,0.0001403892,0.0001459964,0.0003966464],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6133946,0.007222251,0.2439593,0.0009891558,0.005291928,0.0005074081,0.0002890151,0.0012178,0.006694993,0.00009166986,0.003176054,0.1171658],"study_design_scores_gemma":[0.04215709,0.1320883,0.8086764,0.0002291102,0.00654185,0.0007122441,0.0001165636,0.0008431514,0.002336199,0.0001613945,0.006069282,0.00006840224],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9796523,0.01358135,0.000276173,0.0003892987,0.0000708818,0.0003738642,0.003393941,0.00004299149,0.002219156],"genre_scores_gemma":[0.9879236,0.002431795,0.0003174666,0.0007787193,0.0001288965,0.0002660569,0.005902663,0.00001082491,0.002240097],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003053695,"threshold_uncertainty_score":0.0161497,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05455642955437769,"score_gpt":0.4282402993348184,"score_spread":0.3736838697804407,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}